Search Results - Alison Crawford
- Showing 1 - 2 results of 2
-
1
Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer by Min Zhu, Priyanka Madia, Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, Mary Peterman, Thomas S. Uldrick, Elizabeth Miller, John D. Davis, Marc W. Retter
Published in Clinical and Translational Science (2024-12-01)Get full text
Article -
2
293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer by Prashant R Nambiar, Nicole A Protheroe, Kelly DellaGrotte, Harini Kantamneni, Sumati Sundaram, Scott F Heller, Christina Ferren, Collin Walter, Corinne Decker, Alison Crawford, Tina Chang Albershardt
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article
